Regulatory Challenges in Biomaterials: Focus on Medical Devices - Biomaterials Science: An Integrated Clinical and Engineering Approach - page 269

47. Kaitin, K.I., Di Masi, J. 2011. Pharmaceutical Innovation in the 21st century:
New drugs approvals in the first decade, 2000-2009. Clin. Pharmacol. Ther 89(2):
183-188.
48. Schoonmaker, M. 2005. The U.S. approval process for medical devices: Legislative
issues and comparison with the drug model. CRS Report for Congress.
49. Depuy Panel Pack Complete Acetabular Hip System Orthopedic and Rehabilitation
Devices Panel, August 18, 2009. Available at http://www.fda.gov/downloads/
AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/ Medic
alDevicesAdvisoryCommittee/ OrthopaedicandRehabilitationDevicesPanel/
UCM178164.pdf (accessed April 2011).
50. Voskerician, G., et al. 2003. Biocompatibility and biofouling of MEMS drug
delivery devices. Biomaterials 24: 1959-1967.
51. Bajaj, P., et al. 2007. Ultrananocrystalline diamond film as an optimal cell inter-
face for biomedical applications. Biomed Microdevices 9(6): 787-794.
52. Matheny, M.E., Machado, L.O. and Resnic, F.S. 2006. Monitoring device safety in
interventional cardiology. Am Med Inform Assoc . 13: 180-187.
53. Beekman, R.H., et al. 2009. Pathways to approval of pediatric cardiac devices in
the united states: Challenges and solutions. Pediatrics 124: 155-162.
54. Florath, I., et al. 2005. Midterm outcome and quality of life after aortic valve
replacement in elderly people: Mechanical versus stainless steel biological
valves. Heart 91: 1023-1029.
55. Holmes, B.L., et al. 2001. The teratogenicity of anticonvulsant drugs. N. Engl. J
Med 3 44(15): 1132-1138.
56. Jeejeebhoy, F.M. 2009. Prosthetic heart valves and management during preg-
nancy. Canadian Family Physician 55: 155-157.
57. Urizar, G.G., et al. 2004. Psychosocial intervention for a geriatric patient to
address fears related to implantable cardioverter defibrillator discharges.
Psychosomatics 45(2): 140-144.
58. Vidi, V., et al. 2009. Learning curve in the use of star close vascular closure
device: an analysis of national cardiovascular registry data. Poster presented at
the i2Summit, Georgia.
59. Felten, R.P., et al. 2005 Food and Drug Administration medical device review
process: Clearance of a cot retriever for use in ischemic stroke. Stroke 34: 404-406.
60. FDA website http://www.accessdata.fda.gov/cdrh_docs/pdf7/P070005a.pdf
(accessed December, 2010).
61. FDA website http://www.fda.gov/downloads/MedicalDevices/NewsEvents/
WorkshopsConferences/UCM240789.pdf (accessed December, 2010).
62. Hunter, T.B. 2003. Medical devices and foreign bodies: An introduction.
RadioGraphics 23: 193-194.
63. Hunter, T.B., Taljanovic, M.S., Tsau, P.H., Berger, W.G., Standen, J.R. 2004.
Medical devices of the chest. RadioGraphics 24: 1725-1746.
64. Hunter, T.B., and Taljanovic, M.S. 2003. Glossary of medical devices and proce-
dures: abbreviations, acronyms, and definitions. RadioGraphics 23: 195-213.
65. Hunter, T.B., and Taljanovic, M.S. Foreign bodies. 2003. RadioGraphics 23:
731-757.
66. Scott, W.W., Jr, Wheeler, P.S. 1986. Markers for implanted devices: Need for stan-
dardization. AJR 146: 387-390.
67. Wheeler, P.S. 1986. Device identification: Deficient marking systems. AJR 146:
418-419.